NECA inhibited the relative mRNA transcription level of NF-κB and expression of NF-κB protein in DCs of healthy individuals (Figures 2C, D), patients with DM (Figures 3C, D), and BMDCs (Figures 4C, D). This evidence concerns the gene NFKB1 and dermatomyositis.